Ultra-Hypofractionated Adjuvant Radiotherapy for Early Invasive Breast Cancer

Authors

  • Nahla Mokhtar Abdelmawla Morsi, Rehab Hemeda Elsaid Mohamed, Nabila Hefzy Abdelhakeem Ahmed, Alaa Abdelhamed Bahgat Fayed Author

DOI:

https://doi.org/10.48047/3040gm94

Keywords:

Ultra-Hypofractionated, Adjuvant Radiotherapy ,Breast Cancer

Abstract

Background: Adjuvant radiotherapy following breast-conserving surgery is a cornerstone in the management of early invasive breast cancer, 
significantly reducing local recurrence and improving long-term outcomes. Over the past two decades, fractionation schedules have evolved from conventional regimens to moderate hypofractionation, driven by radiobiological insights and robust clinical trial evidence. More recently, ultra-hypofractionated radiotherapy—typically delivered in five fractions over one week—has emerged as a novel paradigm, offering further  treatment acceleration while maintaining oncologic efficacy

Downloads

Download data is not yet available.

References

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-1716. doi:10.1016/S0140-6736(11)61629-2

Downloads

Published

2024-11-20

How to Cite

Ultra-Hypofractionated Adjuvant Radiotherapy for Early Invasive Breast Cancer (Nahla Mokhtar Abdelmawla Morsi, Rehab Hemeda Elsaid Mohamed, Nabila Hefzy Abdelhakeem Ahmed, Alaa Abdelhamed Bahgat Fayed , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6590-6602. https://doi.org/10.48047/3040gm94